AVR compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name

AVRAnteris Technologies Global Corp.

Mkt capRevenueRevenue

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AVRAnteris Technologies Global Corp.

OKUROnKure Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AVR 2

—4Cunlistedcustomer

—LeMaitre Vascularunlistedcustomer

Shared 0

No shared counterparties.

Only OKUR 2

—PharmaBlock Sciences (Nanjing)unlistedsupplier

—STA Pharmaceutical Hong Kongunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AVRAnteris Technologies Global Corp.

6.30· pre 6.54

Mkt cap$615.0MRevenue$1MQ2 FY26Revenue$2MFY25

OKUROnKure Therapeutics, Inc.

2.63· pre 2.63· delayed

Pre-marketSep 2 '83

Mkt cap$106.1MRevenue—Revenue—

Compare

Pre-marketSep 2 '83

AVRAnteris Technologies Global Corp.

OKUROnKure Therapeutics, Inc.

6.30pre 6.54

Price

2.63pre 2.63delayed

$615.0M

Mkt cap

$106.1M

Q2 FY26$1M

Revenue

—

FY25$2M

Revenue

—

AVR6.30vsOKUR2.63Pre-marketSep 2 '83